The role of iron in retinal degeneration during bacterial infection
The role of iron in retinal degeneration during bacterial infection
批准号:
10676039
负责人:
Sierra Foshe
金额:
$4.77万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-07-01 至 2027-02-19
关键词:
AcuteAnimal ModelAnti-Bacterial AgentsAnti-Inflammatory AgentsAntibiotic ResistanceAntibioticsBacteriaBacterial InfectionsBindingBlindnessCell ProliferationCell SurvivalCellsCentral Nervous System InfectionsClinicalColony-forming unitsComplicationDataDiseaseDoseDrug KineticsEndophthalmitisExcisionEyeGenesGoalsGrowthHistologyHourImageImmuneIn SituIn VitroInfectionInflammationInflammatoryInflammatory ResponseInjectionsInjuryInvadedIronIron Chelating AgentsIron ChelationIron OverloadLeadLeftLeukocytesLinkLiquid substanceMacrophageMass Spectrum AnalysisMicrogliaModelingMusNatural regenerationNeuronsOperative Surgical ProceduresOxidative StressPatient-Focused OutcomesPatientsPredispositionProliferatingRegulationRegulator GenesRetinaRetinal DegenerationRetinal DetachmentRetinal DiseasesRoleSalineSortingStainsStaphylococcus aureusStaphylococcus aureus infectionSterilityStructureSurgical complicationSymptomsTestingTimeTissuesVirulenceVisualizationWild Type Mousebacterial endophthalmitiscohortcytokineeffectiveness evaluationimmune activationimprovedin vivomouse modelneurotoxicoperationpathogenic bacteriapreservationpreventpyridineresponsetranslational applicationsuptake
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
When bacteria invade the eye, the resulting damage is rapid and irreversible. This type of infection, called
endophthalmitis, is the most severe complication of intraocular surgery. Patient outcome is heavily dependent
on the pathogenicity of the bacteria, its susceptibility to antibiotics, and the extent of inflammation. These
factors can influence progression to the worst-case scenario, where the infected eye must be completely
removed. Even in milder cases, some amount of permanent vision loss is common. Therefore, there is need
for a treatment which targets both contributors to vision loss: bacterial growth and neurotoxic inflammation. All
bacteria require iron for survival and proliferation. During infection, they must obtain iron from host tissues. In
response, host cells will import iron to shield it from bacteria, initiating a competition for iron acquisition.
However, iron accumulation within immune cells can promote inflammation. In animal models of diverse
infections and diseases, iron chelation is both anti-bacterial and anti-inflammatory. My preliminary ex vivo
data suggests that iron chelation inhibits bacterial growth in vitreous (fluid from within the eye), and that acute
iron chelation is nontoxic to the retina. Aim 1 will expand on these results to determine the effectiveness of an
iron chelator at preventing endophthalmitis in mice. I will examine the extent to which bacterial growth is
inhibited and retinal structure is preserved over time. Although reducing bacteria would naturally reduce
inflammation, the direct anti-inflammatory contribution of iron chelation would be unclear. Therefore, Aim 2 will
investigate the link between iron accumulation and retinal inflammation. Using the murine endophthalmitis
model, I will examine iron levels within retinal macrophages/microglia, and to what extent an iron chelator
reduces retinal inflammation. The result will determine the anti-inflammatory potential of iron chelation
treatment for endophthalmitis. The overall goal of this proposal is to prevent vision loss caused by bacterial
infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金